Sign In
Buy ASLN
$0.600
+0 (+0%)
At Close: Oct 17, 2024
ASLAN Pharmaceuticals Announces the Move of its Primary Listing to Nasdaq and Delisting From Taipei Exchange
10:08am, Friday, 17'th Jul 2020
SINGAPORE, July 17, 2020 -- ASLAN Pharmaceuticals (Nasdaq: ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative.
ASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Buy: Here's Why
04:00pm, Monday, 13'th Jul 2020
ASLAN Pharmaceuticals Ltd. (ASLN) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ASLAN Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
12:06pm, Monday, 13'th Jul 2020
SINGAPORE, July 13, 2020 -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative.
ASLAN Pharmaceuticals (ASLN) Looks Good: Stock Adds 8.7% in Session
12:50pm, Thursday, 25'th Jun 2020
ASLAN Pharmaceuticals (ASLN) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
ASLAN Pharmaceuticals Ltd. (ASLN) Gains As Market Dips: What You Should Know
09:50pm, Friday, 19'th Jun 2020
ASLAN Pharmaceuticals Ltd. (ASLN) closed at $1.92 in the latest trading session, marking a +0.26% move from the prior day.
ASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Buy: Here's What You Should Know
04:00pm, Thursday, 11'th Jun 2020
ASLAN Pharmaceuticals Ltd. (ASLN) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Hedge Funds Souring On ASLAN Pharmaceuticals Limited (ASLN)
01:46am, Friday, 05'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
ASLAN Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
09:34am, Monday, 11'th May 2020
SINGAPORE, May 11, 2020 -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative.
ASLAN Pharmaceuticals Ltd (ASLN) Gains But Lags Market: What You Should Know
09:50pm, Thursday, 07'th May 2020
In the latest trading session, ASLAN Pharmaceuticals Ltd (ASLN) closed at $1.65, marking a +0.61% move from the previous day.
Gilead (GILD) in Focus: Stock Moves 9.7% Higher
12:56pm, Monday, 20'th Apr 2020
Gilead (GILD) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Gilead (GILD) in Focus: Stock Moves 9.7% Higher
12:56pm, Monday, 20'th Apr 2020
Gilead (GILD) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Analysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN), Aslan Pharmaceuticals (ASLN) and BioNTech SE (BNTX)
11:21am, Monday, 13'th Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Urogen Pharma (URGN), Aslan Pharmaceuticals (ASLN) and BioNTech SE
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Urogen Pharma (
URGN
–
Research Report
), Aslan Pharmaceuticals (
ASLN
–
Research Report
) and BioNTech SE (
BNTX
ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today an
Incyte details late-stage data on ruxolitinib cream for atopic dermatitis
06:55pm, Sunday, 05'th Apr 2020
Following up on its initial announcements in January and February, Incyte (NASDAQ:INCY) reports detailed results from two successful Phase 3 clinical trials, TRuE-AD1 and TRuE-AD2, evaluating a topica
